Denmark
· Delayed Price · Currency is DKK Stenocare Statistics
Total Valuation
Stenocare has a market cap or net worth of DKK 25.97 million. The enterprise value is 29.67 million.
| Market Cap | 25.97M |
| Enterprise Value | 29.67M |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Stenocare has 19.98 million shares outstanding. The number of shares has increased by 23.13% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.98M |
| Shares Change (YoY) | +23.13% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 8.37% |
| Owned by Institutions (%) | n/a |
| Float | 9.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.65 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.81 |
| EV / Sales | 13.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.93 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.22 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.37 |
| Interest Coverage | -7.29 |
Financial Efficiency
Return on equity (ROE) is -77.36% and return on invested capital (ROIC) is -34.34%.
| Return on Equity (ROE) | -77.36% |
| Return on Assets (ROA) | -31.90% |
| Return on Capital (ROIC) | -34.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.07 |
| Inventory Turnover | 32.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.95% in the last 52 weeks. The beta is 0.17, so Stenocare's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -53.95% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 3.48 |
| Relative Strength Index (RSI) | 38.06 |
| Average Volume (20 Days) | 101,706 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stenocare had revenue of DKK 2.23 million and -16.40 million in losses. Loss per share was -0.90.
| Revenue | 2.23M |
| Gross Profit | -5.62M |
| Operating Income | -15.51M |
| Pretax Income | -17.56M |
| Net Income | -16.40M |
| EBITDA | -12.12M |
| EBIT | -15.51M |
| Loss Per Share | -0.90 |
Balance Sheet
The company has 52,384 in cash and 3.75 million in debt, giving a net cash position of -3.69 million or -0.18 per share.
| Cash & Cash Equivalents | 52,384 |
| Total Debt | 3.75M |
| Net Cash | -3.69M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | 18.84M |
| Book Value Per Share | 0.94 |
| Working Capital | 979,071 |
Cash Flow
In the last 12 months, operating cash flow was -9.91 million and capital expenditures -220,801, giving a free cash flow of -10.13 million.
| Operating Cash Flow | -9.91M |
| Capital Expenditures | -220,801 |
| Free Cash Flow | -10.13M |
| FCF Per Share | -0.51 |
Margins
| Gross Margin | -251.53% |
| Operating Margin | -694.79% |
| Pretax Margin | -786.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stenocare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.13% |
| Shareholder Yield | -23.13% |
| Earnings Yield | -68.97% |
| FCF Yield | -38.99% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stenocare has an Altman Z-Score of 4.39.
| Altman Z-Score | 4.39 |
| Piotroski F-Score | n/a |